# APLA Health

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/apla-health/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 64.8 |
| Citations | 66,081 |
| City | Los Angeles |
| Country | US |
| Description | APLA Health is a research organisation in Los Angeles, US. OpenAlex records 1,566 works and 66,081 citations for it. 696 researchers list it as their most recent affiliation. |
| Homepage | http://www.apla.org/ |
| OpenAlex ID | https://openalex.org/I1317197149 |
| Region | California |
| Researchers | 696 |
| ROR ID | https://ror.org/05rvwbr49 |
| Type | nonprofit |
| Wikidata ID | https://www.wikidata.org/wiki/Q4651878 |
| Works | 1,566 |

## University papers

Showing 12 of 60.

- [RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrow](https://scholariq.org/papers/retracted-article-pluripotency-of-mesenchymal-stem-cells-derived-from-adult/)
- [Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma](https://scholariq.org/papers/neoadjuvant-anti-pd-1-immunotherapy-promotes-a-survival-benefit-with/)
- [Fatigue in Breast Cancer Survivors: Occurrence, Correlates, and Impact on Quality of Life](https://scholariq.org/papers/fatigue-in-breast-cancer-survivors-occurrence-correlates-and-impact-on-quality/)
- [Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial](https://scholariq.org/papers/previous-radiotherapy-and-the-clinical-activity-and-toxicity-of-pembrolizumab-in/)
- [<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors](https://scholariq.org/papers/i-ras-i-mutations-in-cutaneous-squamous-cell-carcinomas-in-patients-treated-with/)
- [Acute Pancreatitis](https://scholariq.org/papers/acute-pancreatitis/)
- [Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma](https://scholariq.org/papers/neoadjuvant-adjuvant-or-adjuvant-only-pembrolizumab-in-advanced-melanoma/)
- [Quality of Life, Fertility Concerns, and Behavioral Health Outcomes in Younger Breast Cancer Survivors: A Systematic Review](https://scholariq.org/papers/quality-of-life-fertility-concerns-and-behavioral-health-outcomes-in-younger/)
- [Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab](https://scholariq.org/papers/anti-pd-1-therapy-in-patients-with-advanced-melanoma-and-preexisting-autoimmune/)
- [Negative Regulation of Neural Stem/Progenitor Cell Proliferation by the <i>Pten</i> Tumor Suppressor Gene in Vivo](https://scholariq.org/papers/negative-regulation-of-neural-stem-progenitor-cell-proliferation-by-the-i-pten-i/)
- [Immunotherapy response assessment in neuro-oncology: a report of the RANO working group](https://scholariq.org/papers/immunotherapy-response-assessment-in-neuro-oncology-a-report-of-the-rano-working/)
- [Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non–Small Cell Lung Cancer, and Other Solid Tumors](https://scholariq.org/papers/efficacy-and-safety-of-abemaciclib-an-inhibitor-of-cdk4-and-cdk6-for-patients/)

## University researchers

- [Aaron Lisberg](https://scholariq.org/researchers/aaron-lisberg/)
- [Mark D. Girgis](https://scholariq.org/researchers/mark-d-girgis/)
- [Michael S. Oh](https://scholariq.org/researchers/michael-s-oh/)

## University top topics

Showing 8 of 25.

- [HIV/AIDS Research and Interventions](https://scholariq.org/topics/hiv-aids-research-and-interventions/)
- [HIV Research and Treatment](https://scholariq.org/topics/hiv-research-and-treatment/)
- [HIV/AIDS drug development and treatment](https://scholariq.org/topics/hiv-aids-drug-development-and-treatment/)
- [HIV, Drug Use, Sexual Risk](https://scholariq.org/topics/hiv-drug-use-sexual-risk/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Adolescent Sexual and Reproductive Health](https://scholariq.org/topics/adolescent-sexual-and-reproductive-health/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [HIV-related health complications and treatments](https://scholariq.org/topics/hiv-related-health-complications-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.